GLP-1 agonists slow stomach emptying by 30-50%, which means foods that expand in the stomachincluding high-fiber oatmealmay increase nausea or early satiety in some patients
Not if the switch is managed well
The results reported that AngIV had a very short half life of less than 2 minutes, however, each of the N-terminal modified compounds, such as Dihexa, exhibited elongated half-lives in comparison to the parent compound
Lidocaine undergoes extensive first-pass hepatic metabolism, which limits its use to IV administration (26)
Retatrutide is being developed to target multiple metabolic conditions, with its primary uses anticipated to be obesity management, type 2 diabetes, fatty liver disease, and weight-related joint conditions